Rachel Teitelbaum teitelba at aecom.yu.edu
Wed Feb 1 20:21:04 EST 1995

Is anyone familiar with the protocol in Stanford for vaccine therapy for
non-hodgkin's lymphoma?  What precisely are they making immunogenic, and
how effective is the trial?  What are the odds of success?

More information about the Immuno mailing list